Clinical Trials Directory

Trials / Completed

CompletedNCT00345943

An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa

Status
Completed
Phase
Study type
Observational
Enrollment
71 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
Female
Age
12 Years – 17 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to use both multimodal MRI and behavioral measures to investigate how changes in frontostriatal neural systems contribute to the development and persistence of Bulimia Nervosa (BN). Findings from this study will have wide-ranging importance for our understanding of the development and treatment of BN.

Detailed description

Patients with Bulimia Nervosa (BN) have difficulty regulating impulsive behaviors as suggested by their binge-eating and purging, as well as the high incidence of drug abuse and shoplifting in this population. Understanding dysfunction in the frontostriatal circuitry that mediates self-regulatory control processes will aid development of new therapeutics for the impulsivity associated with BN. We are conducting a longitudinal study to better understand the development and persistence of BN. Participation in this study includes 4 sections: Neuropsychological Tests, Diagnostic interviews, Pregnancy Test, and MRI scan. All efforts are made to coordinate procedures into one day, and they require between 4 and 5 hours of the participant's time. The option of splitting participation into two study days is also offered for participants who find it more convenient. Participants are compensated with $100 in the form of a check, which is mailed to their home address. Participants will be invited back for follow-up visits.

Conditions

Interventions

TypeNameDescription
OTHERMRIMagnetic Resonance Imaging scans
BEHAVIORALNeuropsychological TestingNeuropsychological tests

Timeline

Start date
2004-10-01
Primary completion
2016-09-01
Completion
2021-08-01
First posted
2006-06-29
Last updated
2021-12-02
Results posted
2021-12-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00345943. Inclusion in this directory is not an endorsement.